Bolt Biotherapeutics, Inc. SEC filings BOLT
Bolt Biotherapeutics, Inc. has 294 filings in SEC EDGAR's recent list, going back to May 7, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, agreement ended, acquisition or sale of assets, unregistered share sale, officer or director change, bylaw or fiscal year change, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 6, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Oct 2, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Listing notice, Bylaw or fiscal year change
|
Jun 6, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Other events
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2025 | May 27, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 16, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 3, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 4, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 3, 2024 | Jul 2, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Exit or restructuring costs, Officer or director change
|
May 14, 2024 | May 13, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 29, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 14, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 25, 2022 | Jan 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2021 | Dec 13, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2021 | Dec 6, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 19, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Other events
|
Jun 2, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 9, 2021 | Feb 9, 2021 |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BOLT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1641281
- Former names
- Bolt Therapeutics, Inc. (until May 7, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.